drug
OpRegen
Phase 2updated 3mo agoby F. Hoffmann-La Roche Ltd
Phase 2community read0 votes
indications
indications
AMD
all catalysts(0)
nothing on the calendar yet
Trials studying OpRegen
- phase2A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
- phase2Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that